4//SEC Filing
Caudill Cortney 4
Accession 0001159036-25-000075
CIK 0001159036other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:39 PM ET
Size
8.5 KB
Accession
0001159036-25-000075
Insider Transaction Report
Form 4
Caudill Cortney
SVP, CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-01+9,326→ 17,000 total - Sale
Common Stock
2025-11-01$65.19/sh−4,263$277,905→ 12,737 total - Exercise/Conversion
Restricted Stock Units
2025-11-01−9,326→ 18,651 totalExercise: $0.00→ Common Stock (9,326 underlying)
Footnotes (2)
- [F1]The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0002090209
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:39 PM ET
- Size
- 8.5 KB